• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨转移患者骨相关事件的卫生资源利用情况:一项多国回顾性-前瞻性观察性研究的结果——来自4个欧洲国家的队列研究

Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries.

作者信息

Hoefeler H, Duran I, Hechmati G, Garzon Rodriguez C, Lüftner D, Ashcroft J, Bahl A, Atchison C, Wei R, Thomas E, Lorusso V

机构信息

Forschungsszentrum-ruhr, KliFoCenter GmbH, Pferdebachstr. 30, 58455 Witten, Germany.

Hospital Universitario Virgen del Rocio, Avda. Manuel Siurot s/n, 41013 Seville, Spain; Centro Integral Oncologico Clara Campal (CIOCC), Calle Ona 10, 28050 Madrid, Spain.

出版信息

J Bone Oncol. 2014 May 9;3(2):40-8. doi: 10.1016/j.jbo.2014.04.001. eCollection 2014 May.

DOI:10.1016/j.jbo.2014.04.001
PMID:26909296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4723611/
Abstract

BACKGROUND

Skeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, spinal cord compression) frequently occur in patients with advanced cancer with bone metastases/lesions. Limited data on the associated patient and economic burden are available to aid in resource planning and evaluating treatment options.

METHODS

Patients with bone metastases/lesions secondary to breast, lung or prostate cancer or multiple myeloma; with at least one SRE within 97 days prior to enrollment; life expectancy of at least 6 months; and Eastern Cooperative Oncology Group performance status 0, 1 or 2 were recruited. Information on health resource utilization (HRU; including number/duration of hospitalizations, outpatient visits, procedures), attributed by investigators to be associated with a SRE, was collected retrospectively for up to 97 days prior to enrollment and prospectively for up to 18-21 months.

RESULTS

A total of 631 patients contributing 1282 SREs, were enrolled across Germany, Italy, Spain and the United Kingdom. Approximately a third of all SREs required an inpatient stay. Mean duration of inpatient stay for patients with SREs requiring one ranged from 8.4 to 41.1 days across all countries and SRE types.

CONCLUSION

All types of SREs are associated with substantial HRU burden. Preventing SREs by using the best therapeutic options available may help to reduce the burden to patients and healthcare systems.

摘要

背景

骨相关事件(SREs;病理性骨折、骨放疗或手术、脊髓压迫)在伴有骨转移/骨病变的晚期癌症患者中频繁发生。关于相关患者负担和经济负担的可用数据有限,难以用于资源规划和评估治疗方案。

方法

招募继发于乳腺癌、肺癌、前列腺癌或多发性骨髓瘤且伴有骨转移/骨病变的患者;入组前97天内至少发生一次SRE;预期寿命至少6个月;东部肿瘤协作组体能状态为0、1或2。回顾性收集入组前长达97天以及前瞻性收集长达18 - 21个月的、研究者认为与SRE相关的健康资源利用(HRU;包括住院次数/时长、门诊就诊、手术)信息。

结果

德国、意大利、西班牙和英国共入组631例患者,发生1282次SRE。所有SRE中约三分之一需要住院治疗。在所有国家和SRE类型中,因SRE需要住院的患者平均住院时长为8.4至41.1天。

结论

所有类型的SRE均与巨大的HRU负担相关。采用最佳可用治疗方案预防SRE可能有助于减轻患者和医疗系统的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2429/4723611/6807499ea1a5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2429/4723611/33f19cc4f707/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2429/4723611/6807499ea1a5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2429/4723611/33f19cc4f707/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2429/4723611/6807499ea1a5/gr2.jpg

相似文献

1
Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries.骨转移患者骨相关事件的卫生资源利用情况:一项多国回顾性-前瞻性观察性研究的结果——来自4个欧洲国家的队列研究
J Bone Oncol. 2014 May 9;3(2):40-8. doi: 10.1016/j.jbo.2014.04.001. eCollection 2014 May.
2
Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study.晚期乳腺癌患者骨骼相关事件的卫生资源利用情况:一项前瞻性、多国观察性研究的结果
Springerplus. 2014 Jun 30;3:328. doi: 10.1186/2193-1801-3-328. eCollection 2014.
3
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study.欧洲肺癌患者骨骼相关事件的卫生资源利用情况:一项前瞻性多国研究的亚组分析
Mol Clin Oncol. 2014 Sep;2(5):701-708. doi: 10.3892/mco.2014.330. Epub 2014 Jun 27.
4
Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study.欧洲多发性骨髓瘤患者骨骼相关事件的医疗资源利用情况:一项前瞻性、多中心、观察性研究的结果。
Eur J Haematol. 2018 May;100(5):479-487. doi: 10.1111/ejh.13044. Epub 2018 Mar 22.
5
Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study.晚期前列腺癌患者骨骼相关事件的健康资源利用:一项来自观察性跨国研究的欧洲亚组分析
J Clin Med. 2014 Jul 29;3(3):883-96. doi: 10.3390/jcm3030883.
6
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study.欧洲实体瘤伴骨转移患者骨骼相关事件的成本:一项前瞻性多国家观察性研究的数据。
J Med Econ. 2013;16(5):691-700. doi: 10.3111/13696998.2013.779921. Epub 2013 Mar 15.
7
Health resource utilization associated with skeletal-related events: results from a retrospective European study.与骨相关事件相关的卫生资源利用:一项欧洲回顾性研究的结果
Eur J Health Econ. 2016 Jul;17(6):711-21. doi: 10.1007/s10198-015-0716-7. Epub 2015 Aug 8.
8
Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study.实体瘤继发骨转移患者骨骼相关事件的卫生资源利用情况:一项观察性研究中的区域比较
Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12452. Epub 2016 Feb 10.
9
Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.多发性骨髓瘤患者或前列腺癌或乳腺癌继发骨转移患者的病理性骨折、骨手术和脊髓压迫的住院治疗费用。
J Manag Care Pharm. 2010 Nov-Dec;16(9):693-702. doi: 10.18553/jmcp.2010.16.9.693.
10
Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.多发性骨髓瘤患者骨相关事件的经济负担:美国商业索赔数据库分析
J Med Econ. 2018 Jun;21(6):622-628. doi: 10.1080/13696998.2018.1457531. Epub 2018 Apr 12.

引用本文的文献

1
Comparison of efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: A subgroup analysis of a randomized, double-blinded phase III study.拟用生物类似药QL1206与对照药地诺单抗治疗乳腺癌骨转移患者的疗效和安全性比较:一项随机双盲III期研究的亚组分析
Chin J Cancer Res. 2025 Jun 30;37(3):337-351. doi: 10.21147/j.issn.1000-9604.2025.03.04.
2
Incidence, Risk Factors, and Survival of Bone Metastases and Skeletal-Related Events in Melanoma Patients: A Systematic Review and Quality Assessment of 29 Studies.黑色素瘤患者骨转移和骨相关事件的发生率、危险因素及生存率:29项研究的系统评价与质量评估
J Bone Oncol. 2024 Apr 22;46:100603. doi: 10.1016/j.jbo.2024.100603. eCollection 2024 Jun.
3

本文引用的文献

1
Predicting life expectancy in patients with advanced incurable cancer: a review.预测晚期不可治愈癌症患者的预期寿命:一项综述。
J Support Oncol. 2013 Jun;11(2):68-74. doi: 10.12788/j.suponc.0004.
2
Alpha emitter radium-223 and survival in metastatic prostate cancer.α 粒子发射体镭-223 与转移性前列腺癌的生存。
N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.
3
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study.
Narrative review of the epidemiology, economic burden, and societal impact of metastatic bone disease.转移性骨病的流行病学、经济负担及社会影响的叙述性综述
Ann Jt. 2022 Jul 15;7:28. doi: 10.21037/aoj-20-97. eCollection 2022.
4
Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study.常见实体瘤初诊时骨转移的流行率和预后:一项基于人群的研究。
BMJ Open. 2023 Oct 21;13(10):e069908. doi: 10.1136/bmjopen-2022-069908.
5
Comparing the Influence of Surgical and Conservative Therapy on Quality of Life in Patients with Early-Stage Medication-Related Osteonecrosis of the Jaw-A Prospective Longitudinal Study.比较手术和保守疗法对早期药物相关性颌骨骨坏死患者生活质量影响的前瞻性纵向研究。
Medicina (Kaunas). 2023 Jan 31;59(2):277. doi: 10.3390/medicina59020277.
6
Non-Invasive Physical Plasma Generated by a Medical Argon Plasma Device Induces the Expression of Regenerative Factors in Human Gingival Keratinocytes, Fibroblasts, and Tissue Biopsies.医用氩等离子体装置产生的非侵入性物理等离子体可诱导人牙龈角质形成细胞、成纤维细胞和组织活检中再生因子的表达。
Biomedicines. 2022 Apr 13;10(4):889. doi: 10.3390/biomedicines10040889.
7
Biomechanical Properties of Metastatically Involved Osteolytic Bone.转移性溶骨性骨的生物力学特性。
Curr Osteoporos Rep. 2020 Dec;18(6):705-715. doi: 10.1007/s11914-020-00633-z. Epub 2020 Oct 19.
8
State-of-the-art imaging for diagnosis of metastatic bone disease.用于诊断转移性骨疾病的最新成像技术。
Radiologe. 2020 Nov;60(Suppl 1):1-16. doi: 10.1007/s00117-020-00666-6.
9
Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review.五个欧洲国家多发性骨髓瘤患者的骨骼并发症:回顾性患者病历分析。
BMC Cancer. 2020 Mar 3;20(1):170. doi: 10.1186/s12885-020-6596-y.
10
Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17.CXCL17 诱导肺腺癌脊柱转移的机制。
Cell Oncol (Dordr). 2020 Apr;43(2):311-320. doi: 10.1007/s13402-019-00491-7. Epub 2019 Dec 12.
欧洲实体瘤伴骨转移患者骨骼相关事件的成本:一项前瞻性多国家观察性研究的数据。
J Med Econ. 2013;16(5):691-700. doi: 10.3111/13696998.2013.779921. Epub 2013 Mar 15.
4
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.醋酸阿比特龙与泼尼松对比安慰剂与泼尼松在转移性去势抵抗性前列腺癌患者中对疼痛控制和骨骼相关事件的影响:来自 COU-AA-301 随机试验数据的探索性分析。
Lancet Oncol. 2012 Dec;13(12):1210-7. doi: 10.1016/S1470-2045(12)70473-4. Epub 2012 Nov 9.
5
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.地舒单抗优于唑来膦酸预防骨骼相关事件:3 项关键性、随机、3 期临床试验的联合分析。
Eur J Cancer. 2012 Nov;48(16):3082-92. doi: 10.1016/j.ejca.2012.08.002. Epub 2012 Sep 10.
6
Increased survival with enzalutamide in prostate cancer after chemotherapy.恩杂鲁胺可提高化疗后前列腺癌患者的生存率。
N Engl J Med. 2012 Sep 27;367(13):1187-97. doi: 10.1056/NEJMoa1207506. Epub 2012 Aug 15.
7
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.1999-2006 年美国医疗保险受益妇女乳腺癌骨转移和骨骼相关事件后的死亡率:一项基于人群的分析。
Breast Cancer Res Treat. 2012 Jan;131(1):231-8. doi: 10.1007/s10549-011-1721-x. Epub 2011 Aug 13.
8
Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System.转移性乳腺癌或前列腺癌患者骨骼相关事件的医院资源利用和治疗成本:对葡萄牙国家卫生系统的估计。
Value Health. 2011 Jun;14(4):499-505. doi: 10.1016/j.jval.2010.11.014. Epub 2011 May 19.
9
Abiraterone and increased survival in metastatic prostate cancer.阿比特龙与转移性前列腺癌患者的生存获益
N Engl J Med. 2011 May 26;364(21):1995-2005. doi: 10.1056/NEJMoa1014618.
10
Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006.前列腺癌男性患者发生骨转移和骨骼相关事件后的死亡率:1999-2006 年美国医疗保险受益人的基于人群的分析。
Prostate Cancer Prostatic Dis. 2011 Jun;14(2):177-83. doi: 10.1038/pcan.2011.7. Epub 2011 Mar 15.